Quality of Life Impacts of Bright Light Treatment, Fluoxetine, and the Combination in Patients with Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.
Emma MortonErin E MichalakAnthony LevittRobert D LevitanAmy CheungRachel MorehouseRajamannar RamasubbuLakshmi N YathamEdwin M TamRaymond W LamPublished in: Canadian journal of psychiatry. Revue canadienne de psychiatrie (2020)
The findings of this study emphasize that improvement in QoL and reduction in depressive symptoms in MDD, while related, cannot be taken to be synonymous. Adjunctive therapies may be required to address unmet QoL needs in patients with MDD receiving antidepressant or light therapies. Further research is required to explore additional predictors of QoL in order to better refine treatments for MDD.